PEDIATRICS Vol. 45 No. 4 April 1970, pp. 715
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lintermans, J. P.
Right arrow Articles by Seyhnaeve, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lintermans, J. P.
Right arrow Articles by Seyhnaeve, V.

Letter To The Editor

John P. Lintermans M.D. and Victorine Seyhnaeve M.D.

Drs. Lintermans and Seyhnaeve commented as follows:

We agree with Drs. Morris and Phillis Steiner that the use of corticosteroids on our reported case1 might have contributed to the development of tuberculous meningitis 3frac12 months after the initiation of specific therapy for pulmonary tuberculosis. The fact that the infecting organism was isoniazid resistant seems to substantiate this possibility.

On the other hand, documented cases of tuberculous meningitis, due to isoniazid susceptible organisms, developing during the course of chemotherapy (including isoniazid) for pulmonary tuberculosis have been described.2-4